These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 2573323)

  • 41. Suppressed renal response to 2,6-dimethyl clonidine but not clonidine in one kidney-one clip hypertensive rats.
    Li P; Smyth DD
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1395-400. PubMed ID: 7903388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney.
    King PR; Suzuki S; Louis WJ; Gundlach AL
    Ann N Y Acad Sci; 1995 Jul; 763():194-207. PubMed ID: 7677331
    [No Abstract]   [Full Text] [Related]  

  • 43. Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function.
    Diamant S; Eldar-Geva T; Atlas D
    Br J Pharmacol; 1992 May; 106(1):101-8. PubMed ID: 1324063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP; Cardot A; Meyer P
    J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioligand binding and functional assays demonstrate postsynaptic alpha 2-receptors on proximal tubules of rat and rabbit kidney.
    Insel PA; Snavely MD; Healy DP; Münzel PA; Potenza CL; Nord EP
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S9-17. PubMed ID: 2417052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]cirazoline as a tool for the characterization of imidazoline sites.
    Angel I; Le Rouzic M; Pimoule C; Graham D; Arbilla S
    Ann N Y Acad Sci; 1995 Jul; 763():112-24. PubMed ID: 7677320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of [3H]clonidine and [3H]guanfacine binding to alpha 2 adrenoceptors in membranes from rat cerebral cortex.
    Summers RJ; Jarrott B; Louis WJ
    Neurosci Lett; 1981 Aug; 25(1):31-6. PubMed ID: 6269029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anatomical evidence for alpha-2 adrenoceptor heterogeneity: differential autoradiographic distributions of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Loughlin SE; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1079-91. PubMed ID: 3037066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
    Schloos J; Wellstein A; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection and characterization of 3H-clonidine binding sites in coated vesicles isolated from bovine brain.
    Moroi K; Kuga T; Kadota K
    Jpn J Pharmacol; 1989 Sep; 51(1):128-31. PubMed ID: 2572716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-2 adrenoceptor in rat jejunum epithelial cells: characterization with [3H]RX821002 and distribution along the villus-crypt axis.
    Paris H; Voisin T; Remaury A; Rouyer-Fessard C; Daviaud D; Langin D; Laburthe M
    J Pharmacol Exp Ther; 1990 Sep; 254(3):888-93. PubMed ID: 1975626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amiloride interacts with [3H]idazoxan and [3H]rauwolscine binding sites in rabbit urethra.
    Yablonsky F; Dausse JP
    Eur J Pharmacol; 1989 May; 164(1):167-70. PubMed ID: 2568937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype.
    Arnsten AF; Leslie FM
    Neuropharmacology; 1991 Dec; 30(12A):1279-89. PubMed ID: 1686301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Imidazoline-guanidine site: a subtype of imidazoline receptors].
    Coupry I; Limon I; Tesson F; Lachaud V; Gargalidis-Moudanos C; Parini A
    Therapie; 1992 Nov; 47(6):519-24. PubMed ID: 1338740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha 2-adrenoceptor and catecholamine-insensitive binding sites for [3H]rilmenidine in membranes from rat cerebral cortex.
    King PR; Gundlach AL; Jarrott B; Louis WJ
    Eur J Pharmacol; 1992 Jul; 218(1):101-8. PubMed ID: 1356804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-adrenergic binding sites for the "alpha 2-antagonist" [3H] idazoxan in rabbit urethral smooth muscle.
    Yablonsky F; Lacolle JY; Dausse JP
    J Recept Res; 1991; 11(1-4):153-62. PubMed ID: 1679455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antagonist/agonist-preferring alpha-adrenoceptors or alpha 1/alpha 2-adrenoceptors?
    Tanaka T; Starke K
    Eur J Pharmacol; 1980 May; 63(2-3):191-4. PubMed ID: 6103816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nature of [3H]rilmenidine binding to membranes of rat cerebral cortex.
    King PR; Gundlach AL; Jarrott B; Louis WJ
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):64S-68S. PubMed ID: 1350729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.